Edaravone (Radicava): A Novel Neuroprotective Agent for the Treatment of Amyotrophic Lateral Sclerosis
Martin Paspe Cruz, Martin Paspe Cruz
Abstract
Edaravone (Radicava): a novel neuroprotective agent for the treatment of amyotrophic lateral sclerosis.
Conflict of interest statement
Disclosure: The author reports no commercial or financial interests in regard to this article.
Figures
Chemical Structure of Edaravone
Source: PubMed